Atlas Trials

Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)

Clinical trial NCT00154271 · COMPLETED

Trial details

NCT number
NCT00154271
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hypertension
Start date
2004-01-01
Primary completion
2005-06-01
Enrollment
1677

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.